4//SEC Filing
Murali Ramachandran 4
Accession 0001493152-25-008106
CIK 0001962011other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 6:52 PM ET
Size
5.1 KB
Accession
0001493152-25-008106
Insider Transaction Report
Form 4
Murali Ramachandran
VP of Research and Development
Transactions
- Award
COMMON STOCK
2025-01-01+14,000→ 147,057 total
Footnotes (2)
- [F1]Represents 14,000 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 14,000,000 RSUs are scheduled to vest in one third increments on each of 01/01/2025, 09/16/2025, and 09/16/2026. Accordingly, 4,667 RSUs have vested as of the date hereof.
- [F2]Consists of (1) 137,724 shares of common stock and (2) 9,333 RSUs which remain subject to vesting.
Documents
Issuer
Kairos Pharma, LTD.
CIK 0001962011
Entity typeother
Related Parties
1- filerCIK 0001870016
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 6:52 PM ET
- Size
- 5.1 KB